Europe—not US—first to authorize Moderna’s combo mRNA flu-COVID vaccine

Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues ...
CIDRAP

Moderna’s combo flu-COVID vaccine receives European authorization

The world’s first combination seasonal influenza and COVID-19 vaccine, Moderna’s mCombriax, has received marketing ...

Moderna starts late-stage trial for bird flu vaccine

Moderna (MRNA) announced on Wednesday that the company has initiated dosing in a Phase 3 trial designed to evaluate its messenger RNA-based bird flu vaccine candidate, mRNA-1018, in the U.S. and U.K.
European Medical Journal

Moderna initiates phase 3 bird flu vaccine trial

A phase 3 study of Moderna’s investigational mRNA-based H5 pandemic influenza vaccine candidate has been initiated. Read more ...